AXOVANT GENE THERAPIES LTD's ticker is and the CUSIP is G0750W903. A total of 3 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $128,000 | +1063.6% | 27,600 | +607.7% | 0.00% | – |
| Q2 2020 | $11,000 | +1000.0% | 3,900 | +680.0% | 0.00% | – |
| Q1 2020 | $1,000 | -98.7% | 500 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $79,000 | -21.8% | 15,500 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $101,000 | -76.2% | 15,600 | -77.1% | 0.00% | -75.0% |
| Q2 2019 | $425,000 | – | 68,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 68,200 | $425,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,868 | $1,163,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |